Replies to post #49857 on Biotech Values

[apljack]

"St Jude Beats the Street

[ICD sales are on the mend, evidently.]"

And STJ specifically referenced CAMH in their CC. Listen the CC after minute 50:

http://phx.corporate-ir.net/phoenix.zhtml?p=eventDetails&c=73836&

It's clear to the CAMH longs that STJ has in place a strategy for using MTWA as a catalyst for increased ICD sales via developing a more thorough screening program.

Today's CAMH drop below $4 is a disappointment to the faithful, but I see it as a great buying opportunity. For those on the fence, the CC is a must listen.

regards

aj